Real‐world radical cystectomy use in high‐risk non‐muscle‐invasive bladder cancer: a global survey
BJU International · 2026-12 · 138 (6) · 1043-1052
DOI: 10.1111/bju.70480 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift BJU International, online erschienen am 02.10.2026. Verfasst von Jose Luis Dominguez Escrig und 16 weiteren Autor:innen. Beteiligte Einrichtung: Jefe Clínico Servicio de Urología, Fundación Instituto Valenciano de Oncología, Valencia, Spain. Hauptthemen laut MEDLINE: Cystectomy, Non-Muscle Invasive Bladder Neoplasms, Practice Patterns, Physicians', Urinary Bladder Neoplasms. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Johnson and Johnson.
Abstract (Originalsprache)
Objectives
To evaluate real‐world utilisation of radical cystectomy (RC), its acceptance and limitations, and physician perspectives on RC in patients with high‐risk non‐muscle‐invasive bladder cancer (HR‐NMIBC). Patients/Subjects and Methods Data were obtained from the Adelphi Disease Specific Programme™, a multinational, cross‐sectional survey of urologists and medical oncologists treating patients with HR‐NMIBC in China, Japan, Canada, France, Germany, Italy, Spain, and the UK. Physicians reported patient demographics, clinical characteristics, treatment patterns, and patient preferences regarding HR‐NMIBC treatment and surgery.
Results
Overall, 359 physicians provided data for 2583 patients (mean [standard deviation] patient age, 68.9 [9.8] years; 74% male; Stage‐1 [T1] high‐grade tumours 68%). Bacillus Calmette–Guérin (BCG) was used as first‐line treatment in 58% ( n = 1487) of patients. Among patients with recurrent HR‐NMIBC, RC was used in 8% (62 of 802), 7% (13 of 188), and 8% (four of 52) at second line‐of‐treatment, third line‐of‐treatment, and fourth line‐of‐treatment, respectively. Physicians considered 24% of patients likely future RC candidates. Further data were collected on 825 patients who received BCG treatment. Among these patients, RC was offered to 169 (20%); 115 of these patients (68%) refused, most commonly because of quality‐of‐life concerns (87%), unwillingness to have a stoma (60%), and surgical safety concerns (37%).
Conclusion
Despite guideline recommendations, real‐world RC use was low, and most patients offered RC refused it because of quality‐of‐life and safety concerns. These findings highlight an unmet need for alternative and efficacious bladder‐preserving treatments for patients with BCG‐unresponsive HR‐NMIBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Jefe Clínico Servicio de Urología, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
- Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
- Gordon & Leslie Diamond Health Care Centre & Vancouver General Hospital, Vancouver, British Columbia, Canada.
- Department of Urology, Graduate School of Medicine, University of the Ryukyus, Ginowan, Okinawa, Japan.
- Division of Urology and Surgical Oncology, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
- Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
ORCID-Profile: Junichi Inokuchi, Wei Qiang, Lucy Andersen, Brendan Osborne, Laure Manuel, Christopher J D Wallis
Förderung
- Johnson and Johnson
Zitieren
APA
Escrig, J. L. D., Black, P., Inokuchi, J., Kulkarni, G., Qiang, W., Yige, B., Andersen, L., Côté, S., Jain, R., Osborne, B., Deault-Bonin, M., Haughey, S. M., Biondi, E., Manuel, L., Skilling, J., Unsworth, M., & Wallis, C. J. D. (2026). Real‐world radical cystectomy use in high‐risk non‐muscle‐invasive bladder cancer: a global survey. BJU International, 138(6), 1043-1052. https://doi.org/10.1111/bju.70480
Vancouver
Escrig JLD, Black P, Inokuchi J, Kulkarni G, Qiang W, Yige B, et al. Real‐world radical cystectomy use in high‐risk non‐muscle‐invasive bladder cancer: a global survey. BJU International. 2026;138(6):1043-1052. doi:10.1111/bju.70480
BibTeX
@article{Escrig2026,
author = {Escrig, Jose Luis Dominguez and Black, Peter and Inokuchi, Junichi and Kulkarni, Girish and Qiang, Wei and Yige, Bao and Andersen, Lucy and Côté, Sarah and Jain, Ruhee and Osborne, Brendan and Deault-Bonin, Marie and Haughey, Siobhán Mulhern and Biondi, Emilia and Manuel, Laure and Skilling, Jacob and Unsworth, Mia and Wallis, Christopher J D},
title = {Real‐world radical cystectomy use in high‐risk non‐muscle‐invasive bladder cancer: a global survey},
journal = {BJU International},
year = {2026},
volume = {138},
number = {6},
pages = {1043--1052},
doi = {10.1111/bju.70480}
}
EUVIMED